HIGHLIGHTS
- who: . et al. from the Institute of Pharmacology PAS, Poland University of Heidelberg, Germany have published the Article: Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder, in the Journal: (JOURNAL)
- what: As a result of a growing body of evidence that longterm heavy alcohol consumption could activate immune_responses and inflammation (Lo the authors et_al, 2020; Karoly et_al, 2021), this study was designed to explore inflammatory modulators which might be associated with acamprosate treatment outcomes. This study (IRB number: 07-007204) was conducted under protocols reviewed and approved by the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.